BioVentrix has withdrawn its plans to go public, after pitching a Nasdaq IPO earlier this year that aimed to raise about $17 million. In a filing with the SEC, the Massachusetts-based company said the terms of the offering were never set and no securities were sold, following the submission of its S-1 in February. It […]
Funding Roundup
Massachusetts Life Sciences Center offers grants to lower medtech commercial risk
The Massachusetts Life Sciences Center is launching a new kind of grant initiative for early-stage life science companies in the state — not for funding R&D, but instead for measures to reduce commercial risk, including developing go-to-market strategies, planning for regulatory submissions and attracting investment. The Access and Accelerate program will award grants up to […]
Smart ring maker Oura postpones anticipated IPO
The smart ring maker Oura is putting off its Nasdaq IPO, citing market uncertainty shortly after outlining plans to raise as much as $2.2 billion on a $15 billion valuation. In its announcement of the delay, the company said it is still growing and profitable, with 5.7 million users, and it plans to post 90% […]
HighLife raises more than $90M to advance its TMVR system
HighLife (Paris) recently announced it raised €80 million (more than $90 million U.S.) for a U.S. pivotal study and expanded European commercialization of its TMVR system. The successfully completed fundraise, announced Sept. 22, was co-led by Andera Partners, Sofinnova Partners, Supernova Invest and Mérieux Equity Partners. Other new investors joining the round included the European […]
UltraSight raises $24M in Series B2 to scale AI-guided cardiac ultrasound technology
AI-guided cardiac technology developer UltraSight has raised $24 million in Series B2 financing, the company announced. The financing will support the company’s commercial expansion in the United States and the development of new software systems for intensive care and circulatory support settings, UltraSight said. Alive HealthTech Grow Fund led the round with an undisclosed investment. […]
Anaconda Biomed brings in $56 million
Anaconda Biomed recently announced a $56 million funding round to advance what it describes as next-generation, novel thrombectomy catheters. The Barcelona-based company said the funds will support completion of the ongoing Athena pivotal IDE study, a prospective, randomized, 327-subject trial intended to evaluate the safety and performance of the ANA Funnel Catheter. Omega Funds led […]
Precision Neuroscience raises $250M in Series D for its BCI
Brain-computer interface developer Precision Neuroscience has raised $250 million in an oversubscribed Series D, which the company said reflects investor conviction in BCI as a consequential emerging medtech. Pershing Square, the Ackman Oxman Institute, and an undisclosed leading life sciences investment fund co-led the round. Additional participants include the Duquesne Family Office, B Capital, ARK […]
Verily Health secures investment from Nvidia to advance healthcare AI platforms
Verily Health secured an investment from Nvidia to advance development and commercial deployment of its precision healthcare AI platforms, the company announced today. Verily also received an additional investment from existing investor CU Healthcare Innovation Fund. “We are pleased to welcome Nvidia as a new investor in Verily. These investments strengthen our ability to pursue […]
Elucid raises $55M Series D for cardio imaging tech
Elucid announced the end of its Series D financing round, having raised $55 million and bringing the company’s total funds raised to date to $185 million. The Boston-based company will utilize the investments to accelerate commercial expansion of its FDA-cleared plaque assessment tool, Plaque-IQ, and its non-invasive fractional flow reserve—computed tomography (FFR-CT) analysis system, pending […]
Medtronic structural heart leader appointed CEO of Versa Vascular
Versa Vascular appointed Bill Shields as its new CEO, the company announced today. Shields joins Versa after 15 years with Medtronic’s structural heart business. Most recently, Shields was VP and GM of Medtronic’s Transcatheter Mitral and Tricuspid Therapies business. He spent seven years in the transcatheter mitral and tricuspid segment leading product development and multiple clinical […]
Vexev raises $6M to support robotic ultrasound tech
Vexev announced today that it raised $6 million in new funding to accelerate the progress of its robotic tomographic ultrasound platform. Existing investors Blackbird Ventures, Neotribe Ventures, Startmate and Horizon participated in the round. New investors TreeArc Investment Group, TEN13, Bioshore Ventures and Alumni Ventures all joined as well. The company plans to use funds to […]
